HCA Previews 2017 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
HCA Holdings (HCA) PT Lowered to $90 at Jefferies Following 3Q Pre-Announcement
October 19, 2017 8:48 AM EDTJefferies lowered its price target on HCA Holdings (NYSE: HCA) to $90.00 (from $92.00) while maintaining a Buy rating following the company's 3Q pre-announcement. HCA pre-announced Q3 EBITDA of $1.776B vs. $1.97B consensus. EBITDA was dragged down by the hurricanes ($140MM) and a TX Medicaid... More
